Position in NVO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,363,470
+$2,867,544 QoQ
Shares Held
70,160
+1584.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#280
of 1,348 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $25,845,902 across 12 Drug Manufacturers - General names. NVO ranks #4 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,681 | $7,217,286 | |
| 2 | NVS |
Novartis AG
|
26,136 | $4,096,033 | |
| 3 | JNJ |
Johnson & Johnson
|
13,995 | $3,554,310 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
70,160 | $3,363,470 | |
| 5 | MRK |
Merck & Co., Inc.
|
24,621 | $3,163,798 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,721 | $1,366,804 | |
| 7 | LLY |
ELI LILLY & Co
|
971 | $1,164,646 | |
| 8 | AZN |
Astrazeneca PLC
|
3,262 | $618,540 |
All Filings in NVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,363,470 | 70,160 | Shares | Sole | 2026-07-30 | |
| 2024-09-30 | $495,926 | 4,165 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,022,732 | 7,165 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $765,906 | 5,965 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $264,832 | 2,560 | Shares | Sole | 2024-02-05 | |
| No filing history on record for this holder in this stock. | ||||||